Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Verve Therapeutics Inc. Common Stock (NASDAQ: VERV)

 
VERV Technical Analysis
5
As on 9th Jun 2023 VERV STOCK Price closed @ 17.19 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 26.88 & Strong Sell for SHORT-TERM with Stoploss of 31.95 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VERVSTOCK Price

Open 17.79 Change Price %
High 17.83 1 Day -0.40 -2.27
Low 17.15 1 Week 1.20 7.50
Close 17.19 1 Month 1.47 9.35
Volume 366437 1 Year -22.08 -56.23
52 Week High 41.49 | 52 Week Low 11.14
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
VERV
Daily Charts		 VERV
Intraday Charts		 Whats New @
Bazaartrend		 VERV
Free Analysis
 
VERV Important Levels Intraday
RESISTANCE18.50
RESISTANCE18.08
RESISTANCE17.82
RESISTANCE17.56
SUPPORT16.82
SUPPORT16.56
SUPPORT16.30
SUPPORT15.88
 
VERV Forecast April 2024
Share
4th UP Forecast40.91
3rd UP Forecast33.3
2nd UP Forecast28.6
1st UP Forecast23.9
1st DOWN Forecast10.48
2nd DOWN Forecast5.78
3rd DOWN Forecast1.08
4th DOWN Forecast-6.53
 
VERV Weekly Forecast
4th UP Forecast33.16
3rd UP Forecast28.04
2nd UP Forecast24.87
1st UP Forecast21.71
1st DOWN Forecast12.67
2nd DOWN Forecast9.51
3rd DOWN Forecast6.34
4th DOWN Forecast1.22
 
VERV Forecast2024
4th UP Forecast79.43
3rd UP Forecast59.47
2nd UP Forecast47.13
1st UP Forecast34.79
1st DOWN Forecast-0.41
2nd DOWN Forecast-12.75
3rd DOWN Forecast-25.09
4th DOWN Forecast-45.05
 
 
VERV Other Details
Segment EQ
Market Capital 2255134720.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VERV Address
VERV
 
VERV Latest News
 
Your Comments and Response on Verve Therapeutics Inc. Common Stock
 
VERV Business Profile
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is based in Cambridge, Massachusetts. Address: 500 Technology Square, Cambridge, MA, United States, 02139
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service